1MG majority stake to be acquired by Tata Digital

Published On 2021-06-11 04:30 GMT   |   Update On 2021-06-11 12:31 GMT

New Delhi: Tata Digital Ltd, a wholly-owned arm of Tata Sons, on Thursday said it will acquire a majority stake in 1MG Technologies Ltd, an online healthcare marketplace.

The company, however, did not disclose the financial details of the transaction.

Just days after the company said it will invest USD 75 million (around Rs 550 crore) in fitness-focused Curefit Healthcare for an undisclosed stake, Tata Digital said its investment in 1MG is in line with Tata Group''s vision of creating a digital ecosystem which addresses the consumer needs across categories in a unified manner.

Tata Digital said e-pharmacy, e-diagnostics and tele-consultation are critical segments in this ecosystem and have been among the fastest growing segments in this space, as this sector enabled access to healthcare through the pandemic.

The overall market is around USD 1 billion and is expected to grow at around 50 per cent Compound Annual Growth Rate (CAGR) driven by increased health awareness among consumers and greater convenience. This category will form a key element of the Tata Digital ecosystem offering.

"The investment in 1MG strengthens Tata''s ability to provide superior customer experience and high quality healthcare products & services in the e-pharmacy and e-diagnostics space through a technology-led platform," Tata Digital CEO Pratik Pal said in a statement.

1MG Co-founder and CEO Prashant Tandon said, the investment by the Tatas "marks a significant milestone in 1MG''s journey to make high-quality healthcare products and services accessible to customers across India."

Started in 2015, 1MG is among the leading players in the eHealth space and enables easy and affordable access to a wide range of products like medicines, health and wellness products, diagnostics services and tele-consultation to customers.

The company currently operates three state-of-the-art diagnostic labs, has a supply chain covering over 20,000 pincodes across the country and through its subsidiaries is also engaged in the business of B2B distribution of medicines & other healthcare products, the statement said.

On Monday, Tata Digital had announced that it would invest USD 75 million (around Rs 550 crore) in fitness-focused Curefit Healthcare for an undisclosed stake.

Curefit''s founder and chief executive Mukesh Bansal will join Tata Digital in an executive role as its president, an official statement had said, adding will continue in his leadership role at Curefit as well.

The salt-to-software conglomerate Tata group has been on an acquisition spree in the e-commerce space. Last month it had acquired a majority stake in online grocery seller BigBasket for an undisclosed sum of money, pitting it against the likes of billionaire Mukesh Ambani''s Reliance and Amazon.

The deal would pit the salt-to-software conglomerate against Ambani''s JioMart, Amazon and Walmart''s Flipkart for a pie of the online grocery business that has grown exponentially during the pandemic.

About half of India''s USD 1 trillion-retail market comprises grocery sales. The online grocery market is expected to reach USD 4.3 billion in 2021 from USD 2.9 billion in the previous year.

Read also: 1mg kick starts massive cancer campaign



Tags:    
Article Source : PTI

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News